vimarsana.com

Page 11 - Nccn Guidelines News Today : Breaking News, Live Updates & Top Stories | Vimarsana

NCCN-Directed Guidelines Driving PV Treatment in Clinical Practice

Dr. Gerd examines the clinical choices involved in the management of PV, following the directives of NCCN guidelines.

United statesAaron gerdsAmerican society hematologyNorth americaNccn guidelinesPolycythemia veraMyeloproliferative neoplasm

Prostate Cancer Prognosis and Risk Stratification

Rashid K. Sayyid, MD, MSc, describes the staging and risk stratification process for patients with prostate cancer and their effect on prognosis.

Prostate cancer treatment landscapeCancer prognosisProstate cancerProstate cancer stagingProstate cancer prognosisProstate cancer treatmentsMetastatic prostate cancerProstate cancer risk stratificationNccn guidelinesGleason score

Ruxolitinib in the Treatment of PV

Key opinion leaders discuss data on the use of ruxolitinib in patients with polycythemia vera.

Treatment approachExpert insights intoPolycythemia veraTreatment advanced polycythemia veraPolycythemia vera treatmentsPv treatmentsRisk assessment polycythemia veraPatients with polycythemia veraHealth insuranceHealth insurance approvalsNccn guidelinesCo payCommunity clinicsCommunity physiciansPatient assistance programsFinancial toxicity

Multiple Myeloma: Regulatory Aspects of Treatment Development and Approval

A focused discussion on the regulatory aspects of drug testing and approval, globally, with respect to the setting of multiple myeloma management.

United statesUnited kingdomKatie joynerJoseph mikhaelSouth americanLatin americaWestern europeanEastern europeanMultiple myelomaNewly diagnosed multiple myelomaFrontline therapyFirst line therapyFirst line treatmentTreatment pathwaysTreatment regulationTherapy regulation

Treatment Approaches for High-Risk Patients With PV

Drs Joe Scandura and John Mascarenhas discuss their treatment approaches for high-risk patients with polycythemia vera.

John mascarenhasJoe scanduraTreatment approachExpert insights intoPolycythemia veraHigh risk patients withTreatment advanced polycythemia veraPolycythemia vera treatmentsPv treatmentsRisk assessment polycythemia veraPatients with polycythemia veraHealth insuranceHealth insurance approvalsNccn guidelinesCo payCommunity clinics

vimarsana © 2020. All Rights Reserved.